Subcutaneous insulin aspart vs intravenous regular insulin
Adverse events other than hypoglycaemic episodes
The review found no eligible studies for this question.
1 finding from 1 review
- Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found